GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dr Reddy's Laboratories Ltd (BSP:R1DY34) » Definitions » Shiller PE Ratio

Dr Reddy's Laboratories (BSP:R1DY34) Shiller PE Ratio : 38.43 (As of Apr. 28, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Dr Reddy's Laboratories Shiller PE Ratio?

As of today (2024-04-28), Dr Reddy's Laboratories's current share price is R$62.64. Dr Reddy's Laboratories's E10 for the quarter that ended in Dec. 2023 was R$1.63. Dr Reddy's Laboratories's Shiller PE Ratio for today is 38.43.

The historical rank and industry rank for Dr Reddy's Laboratories's Shiller PE Ratio or its related term are showing as below:

BSP:R1DY34' s Shiller PE Ratio Range Over the Past 10 Years
Min: 21.64   Med: 33.25   Max: 55.96
Current: 35.58

During the past years, Dr Reddy's Laboratories's highest Shiller PE Ratio was 55.96. The lowest was 21.64. And the median was 33.25.

BSP:R1DY34's Shiller PE Ratio is ranked worse than
69.44% of 517 companies
in the Drug Manufacturers industry
Industry Median: 24.4 vs BSP:R1DY34: 35.58

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Dr Reddy's Laboratories's adjusted earnings per share data for the three months ended in Dec. 2023 was R$0.811. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is R$1.63 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Dr Reddy's Laboratories Shiller PE Ratio Historical Data

The historical data trend for Dr Reddy's Laboratories's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Reddy's Laboratories Shiller PE Ratio Chart

Dr Reddy's Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.95 24.41 33.62 30.47 28.97

Dr Reddy's Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.74 28.97 30.68 32.56 32.99

Competitive Comparison of Dr Reddy's Laboratories's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Dr Reddy's Laboratories's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dr Reddy's Laboratories's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dr Reddy's Laboratories's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Dr Reddy's Laboratories's Shiller PE Ratio falls into.



Dr Reddy's Laboratories Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Dr Reddy's Laboratories's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=62.64/1.63
=38.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dr Reddy's Laboratories's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Dr Reddy's Laboratories's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.811/153.2548*153.2548
=0.811

Current CPI (Dec. 2023) = 153.2548.

Dr Reddy's Laboratories Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 0.179 91.425 0.300
201406 0.201 94.103 0.327
201409 0.215 96.780 0.340
201412 0.236 96.780 0.374
201503 0.254 97.163 0.401
201506 0.297 99.841 0.456
201509 0.415 101.753 0.625
201512 0.329 102.901 0.490
201603 0.040 102.518 0.060
201606 0.063 105.961 0.091
201609 0.144 105.961 0.208
201612 0.233 105.196 0.339
201703 0.149 105.196 0.217
201706 0.030 107.109 0.043
201709 0.139 109.021 0.195
201712 0.172 109.404 0.241
201803 0.153 109.786 0.214
201806 0.254 111.317 0.350
201809 0.287 115.142 0.382
201812 0.267 115.142 0.355
201903 0.241 118.202 0.312
201906 0.370 120.880 0.469
201909 0.634 123.175 0.789
201912 -0.330 126.235 -0.401
202003 0.503 124.705 0.618
202006 0.398 127.000 0.480
202009 0.561 130.118 0.661
202012 0.014 130.889 0.016
202103 0.429 131.771 0.499
202106 0.391 134.084 0.447
202109 0.713 135.847 0.804
202112 0.531 138.161 0.589
202203 0.057 138.822 0.063
202206 0.769 142.347 0.828
202209 0.728 144.661 0.771
202212 0.794 145.763 0.835
202303 0.609 146.865 0.635
202306 0.829 150.280 0.845
202309 0.880 151.492 0.890
202312 0.811 153.255 0.811

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Dr Reddy's Laboratories  (BSP:R1DY34) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Dr Reddy's Laboratories Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Dr Reddy's Laboratories's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Dr Reddy's Laboratories (BSP:R1DY34) Business Description

Address
8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, IND, 500 034
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (22% of its generics sales), Russia (12%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Dr Reddy's Laboratories (BSP:R1DY34) Headlines

No Headlines